elranatamab will raise the stage or effect of fentanyl transdermal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Elranatamab causes cytokine launch syndrome (CRS) which will suppress exercise of CYP enzymes, resulting in elevated publicity of CYP substrates.Whilst the US worked with China to crack down on a person